fingolimod hydrochloride

Italy

Drugs containing this active substance

  • FINGOLIMOD MEDICAL VALLEY

    It is used in adults and children and adolescents (from 10 years of age and older) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or who present with a severe, rapidly progressing form. It helps to reduce the number of relapses and to slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod hydrochloride -

    ATC: L04AE01

    Manufacturer: MEDICAL VALLEY INVEST AB

  • FINGOLIMOD MYLAN ITALIA

    It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children/adolescents (from 10 years of age onwards), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod hydrochloride -

    ATC: L04AE01

    Manufacturer: MYLAN S.P.A.

  • FINGOLIMOD TOWA

    It is used for the treatment of relapsing-remitting multiple sclerosis (RRMS) in adults and children/adolescents aged 10 years and older, particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod hydrochloride -

    ATC: L04AA27

    Manufacturer: TOWA PHARMACEUTICAL S.P.A.

  • GANEXIM

    It is used in adults and children and adolescents (from 10 years of age and older) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for patients who have not responded to other therapies or who present with a severe, rapidly progressing form. It does not cure the disease, but it helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod hydrochloride -

    ATC: L04AA27

    Manufacturer: BAUSCH HEALTH IRELAND LIMITED

  • NAEGOTI

    It is used in adults and children and adolescents (from 10 years of age onwards) for the treatment of relapsing-remitting multiple sclerosis (RRMS), particularly for those who have not responded to other therapies or for those with a severe, rapidly progressing form. It helps to reduce relapses and slow the progression of physical disability.

    Form: capsules, hard gelatin

    Active substance Dosage
    fingolimod hydrochloride -

    ATC: L04AA27

    Manufacturer: MEDAC PHARMA SRL